Transcatheter interatrial shunt device provides sustained clinical benefit at one year in patients with preserved or mildly reduced ejection fraction: the REDUCE LAP heart failure trial

Saved in:
Bibliographic Details
Main Authors: Kaye, David M. (Author) , Raake, Philip (Author)
Format: Article (Journal)
Language:English
Published: 20 December 2016
In: Circulation
Year: 2016, Volume: 134, Issue: 25, Pages: e707
ISSN:1524-4539
DOI:10.1161/CIR.0000000000000472
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1161/CIR.0000000000000472
Verlag, kostenfrei, Volltext: http://ovidsp.tx.ovid.com/sp-3.26.1a/ovidweb.cgi?&S=JHDAFPIBBLDDNGGFNCGKHEJCHIPAAA00&Link+Set=S.sh.22.23.27.31%7c14%7csl_10
Get full text
Author Notes:David Kaye, Gerd Hasenfuß, Petr Neuzil, Marco Post, Rob Doughty, Jean-Noel Trochu, Adam Kolodziej, Ralf Westenfeld, Martin Penicka, Mark Rosenberg, Jörg Hausleiter, Philip Raake, Mark Petrie, Martin Bergmann, Guillaume Jondeau, Frank Silvestry, Chris Hayward
Description
Item Description:Gesehen am 15.08.2017
Physical Description:Online Resource
ISSN:1524-4539
DOI:10.1161/CIR.0000000000000472